CoChat

Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling

Open access
Raybould, Matthew I. J., Turnbull, Oliver M., Suter, Annabel, Guloglu, Bora, Deane, Charlotte M. · 2024 · Communications Biology
Cited by 42

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Antibodies with lambda light chains ( λ -antibodies) are generally considered to be less developable than those with kappa light chains ( κ -antibodies). Though this hypothesis has not been formally established, it has led to substantial systematic biases in drug discovery pipelines and thus contributed to kappa dominance amongst clinical-stage therapeutics. However, the identification of increasing numbers of epitopes preferentially engaged by λ -antibodies shows there is a functional cost to neglecting to consider them as potential lead candidates. Here, we update our Therapeutic Antibody Profiler (TAP) tool to use the latest data and machine learning-based structure prediction, and apply it to evaluate developability risk profiles for κ -antibodies and λ -antibodies based on their surface physicochemical properties. We find that while human λ -antibodies on average have a higher risk of developability issues than κ -antibodies, a sizeable proportion are assigned lower-risk profiles by TAP and should represent more tractable candidates for therapeutic development. Through a comparative analysis of the low- and high-risk populations, we highlight opportunities for strategic design that TAP suggests would enrich for more developable λ -antibodies. Overall, we provide context to the differing developability of κ - and λ -antibodies, enabling a rational approach to incorporate more diversity into the initial pool of immunotherapeutic candidates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-023-05744-8

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 42

Metadata

Authors
Raybould, M. I. J., Turnbull, O. M., Suter, A., Guloglu, B., & Deane, C. M.
Venue
Communications Biology
Published
2024-01-08
Volume
7
Issue
1
Pages
62-62
ISSN
2399-3642 (ISSN-L)
OpenAlex
W4390661248
Cited by
42
References
13
FWCI
9.43
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling. https://app.cochat.ai/papers/10.1038/s42003-023-05744-8
The paper
Raybould, M. I. J., Turnbull, O. M., Suter, A., Guloglu, B., & Deane, C. M. (2024). Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling. Communications Biology. https://doi.org/10.1038/s42003-023-05744-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.